<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="92331">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01798654</url>
  </required_header>
  <id_info>
    <org_study_id>H-Spirit1201</org_study_id>
    <nct_id>NCT01798654</nct_id>
  </id_info>
  <brief_title>EUS-FNA for Patients With Antithrombotic Agents</brief_title>
  <official_title>Safety of Endoscopic Ultrasound-guided Fine Needle Aspiration for Patients With Antithrombotic Agents</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hokkaido Pancreatobiliary Endoscopic Intervention Study Group</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hokkaido University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hokkaido Pancreatobiliary Endoscopic Intervention Study Group</source>
  <oversight_info>
    <authority>Japan: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study to evaluate a safety of endoscopic ultrasound-guided fine needle
      aspiration (EUS-FNA) for patients with antithrombotic agents.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2012</start_date>
  <primary_completion_date type="Anticipated">September 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Patients who suffered bleeding complication</measure>
    <time_frame>One week</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Solid Tumor</condition>
  <arm_group>
    <arm_group_label>Antithrombotic agents</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        In hospital
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Undergo EUS-FNA

          -  take antithrombotic agents

        Exclusion Criteria:

          -  Cystic lesion
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Kazumichi Kawakubo, MD, PhD</last_name>
    <phone>81117161161</phone>
    <email>kkawakubo-gi@umin.ac.jp</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hokkaido University Graduate School of Medicine</name>
      <address>
        <city>Sapporo</city>
        <zip>0808648</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Japan</country>
  </location_countries>
  <verification_date>February 2013</verification_date>
  <lastchanged_date>February 25, 2013</lastchanged_date>
  <firstreceived_date>February 22, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hokkaido Pancreatobiliary Endoscopic Intervention Study Group</investigator_affiliation>
    <investigator_full_name>Kazumichi Kawakubo</investigator_full_name>
    <investigator_title>M.D. and Ph.D.</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Fibrinolytic Agents</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
